加载中...
共找到 39,036 条相关资讯
The second-longest ever winning streak for the S&P 500 was broken on Monday, 20 April 2026. The streak had endured for 13 days, one short of the all-time record.
China's DeepSeek has rolled out preview versions of a new flagship artificial intelligence model, calling it its most powerful open-source platform. Bloomberg Intelligence's Robert Lea explains how the Chinese flagship system is hampered in some areas by a lack of access to Nvidia tech but playing to its strengths in others.
Experts say quantum computing can reshape areas ranging from new drug discovery to machine learning and risk modeling in finance. But it's also thought to be still years away from offering many practical solutions.
Market indices, including the S&P 500 and Nasdaq, have broken out of their new highs despite ongoing geopolitical risks and energy disruption worries. Q1 earnings have broadly surpassed expectations, with technology, especially chips, leading sector growth amid an intensifying AI arms race.
Stocks hit new all-time highs, fueled by strong earnings and optimistic geopolitical rhetoric, but underlying risks remain unresolved. The S&P 500 trades at a 20.9x forward P/E, above historical averages, while consensus earnings growth expectations appear overly optimistic amid persistent inflation and global headwinds.
The “20% of global oil closed” framing was always misleading. In reality, the reduction in impact came primarily from four forces, and the primary source documents each.
Investors should continue using geopolitically driven market weakness as a buying opportunity, according to JP Morgan's equity strategy team, which says the conditions that argued against a prolonged conflict-driven selloff remain firmly in place. The bank's strategist Mislav Matejka, who called in March for investors to add on dips following the initial derisking phase, says central bank flexibility and supportive earnings momentum distinguish the current environment sharply from 2022, when rising rates compounded equity market pain.
Jeremy Siegel, professor emeritus of finance at University of Pennsylvania's Wharton School of Business and WisdomTree chief economist, joins 'Squawk Box' to discuss the future of the Federal Reserve, state of the economy, latest market trends, and more.
Peter Boockvar, CIO at One Point BFG Wealth Partners, Lee Baker, Owner and President of Claris Financial Advisors, and Courtney Gelman, Washington Research Analyst at Strategas, say AI spending and earnings will drive markets this week
An uneven rally is just one reason why the Goldman Sachs trading desk is bracing for a pullback after the S&P 500's ninth record close last week.
Market research technology firm Cint gained a third in value on Monday after its top shareholder and managers teamed up with UK fund Triton Partners to take the Swedish company private.
Wall Street futures were little changed on Monday as Iran peace negotiations stalled and fresh Strait of Hormuz tensions pushed oil prices sharply higher, setting a cautious tone ahead of one of the most consequential weeks of the year. S&P 500 futures hovered near the flat, Nasdaq-100 futures edged 0.2% higher, and Dow futures slipped almost 60 points as investors weighed geopolitical risk against a packed corporate calendar.
Stock outperformance hinges on disciplined price entry, not just fundamentals, growth, or narrative. Elevating price as a primary investment criterion enables outperformance, especially when combined with patience and incremental buying on weakness.
Wall Street's busiest week of the year starts off with more worries about oil, Iran and the Strait of Hormuz.
Oruka Therapeutics said on Monday that interim results showed its experimental drug helped clear psoriasis within 16 weeks, meeting the main goal of a mid-stage study and sending shares up 43.4% in premarket trading.
The eight heirs of late Ray-Ban billionaire Leonardo Del Vecchio have approved a proposal by one of them to buy out two other siblings in a 10 billion euro ($11.7 billion) deal, a source close to the matter said on Monday.
A Supreme Court case and a bill moving through Congress this week are set to again test the bonds of Republicans and the Make America Healthy Again movement after a near-rupture in February over the weedkiller glyphosate. The court will hear a case Monday to decide whether federal law preempts state-level lawsuits alleging glyphosate, the chemical in Bayer's weedkiller Roundup, causes cancer.
HawkEye 360 is targeting a valuation of up to $2.42 billion in its initial public offering in the United States, the space analytics company said on Monday.
It could be years until quantum computing delivers on its promise to revolutionize everything from financial trading to drug discovery. But that's not stopping the companies developing quantum hardware and software from speeding headlong into the public markets.
Warsh nomination clears last major obstacle, SpaceX unveils IPO secret weapon, prediction market faces scrutiny, and more news to start your day.